Editor Profile

Anne S. Tsao, MD

Associate Editor

About the NEJM Journal Oncology and Hematology Board

Dr. Tsao is an Associate Professor in the Department of Thoracic/Head & Neck Medical Oncology at the University of Texas M.D. Anderson Cancer Center (MDACC). She is the Director of the Mesothelioma Program and the Director of the Thoracic Chemo-Radiation Program at MDACC. Dr. Tsao is a clinician scientist and an expert in the treatment of patients with both thoracic and head and neck cancers. She conducts both clinical and translational laboratory research and focuses on identifying new therapeutic targets and developing novel strategies for the treatment of aerodigestive cancers and mesothelioma. Her research concentrates on individualizing cancer therapy through understanding the molecular mechanisms of disease. Dr. Tsao serves on the SWOG Mesothelioma Steering Committee, SWOG Lung Executive Committee, IASLC Communications Committee, and RTOG Lung Executive Committee, and is on the Scientific Board of the American Radium Society. She has been an Associate Editor of NEJM Journal Watch Oncology and Hematology since June 2013.


Consultant / Advisory board
Genetech; Roche; Medimmune; Novartis; Astellas; Boehringer-Ingelheim; Eli Lilly
Speaker's bureau

Genetech; Roche; Medimmune; Novartis; Astellas; Boehringer-Ingelheim; Eli Lilly

Grant / Research support

Department of Defense; SWOG

Leadership positions in professional societies

American Medical Association (Member); American Association of Cancer Research (Member); American Society of Clinical Oncology (Member); AACR-Women in Cancer Research (Member); International Mesothelioma Interest Group (Member); SWOG (Member); International Association for the Study of Lung Cancer (Communications Committee Chair); American Radium Society (Chair); RTOG (Member)

Summaries by Anne Tsao